Dr. Andrea Weiland-Waibel, Explicat Pharma GmbH - Qepler Summits And Conferences

Dr. Andrea Weiland-Waibel

Managing Director
Explicat Pharma GmbH
Germany
Biopharma Group - Freeze Drying Equipment & After Sales Support Benchtop, Laboratory & Production Scale Vial Handling Solutions & Aseptic Proccessing Lines Volumetric Powder Fillers (UK & Europe) High Pressure Homogenisers Solvent Evaporators / Concentrators Preparative Chromatography Solutions

Andrea Weiland, Ph.D., is managing director of Explicat® Pharma GmbH, a company providing technical project management services and pharmaceutical development services to the Pharmaceutical Industry (CMC).

Andrea is a pharmacist with a Ph.D. in pharmaceutical technology on biodegradable microspheres and cyclodextrins . She held several leadership positions within Pfizer, working as project manager in process technology and within R&D where she was responsible scientist for pharmaceutical development (Phase I - III, candidate characterization and lyophilisation projects).

Related Sessions:

3rd Annual Pharmaceutical
Lyophilization Summit 2021

Discuss best practices in tech & regulatory updates, process, formulation, testing, monitoring, new products development.
  • 29 Jul 2021
  • Virtual,
  • Pharma
Day 2: Friday, 30 July 2021
CASE STUDY: Lyocycle Development and Transfer/Process Performance Qualification of an amorphous cyclodextrin based lyoproduct into production scale and experiences during routine production.
  • Critical Quality Attributes of Lyo Products
  • The Critical Formulation Temperature and the rational design of the lyocycle
  • Lyocycle robustness and the Transfer/PPQ into routine production
  • Ongoing Process Verification during lifecycle, experiences during routine production
View Details